DESCRIPTION:

This pen contains a dual peptide blend of CJC 1295 and Ipamorelin. These two peptides are often researched together for their synergistic activity in stimulating natural growth hormone release. CJC 1295 is a growth hormone releasing hormone analogue while Ipamorelin is a growth hormone releasing peptide. Each interacts with different receptor pathways inside the pituitary system and together they can support increased GH pulse frequency and amplitude.

Properties and Effects

• Supports improved natural growth hormone signaling

• Encourages better recovery and repair after physical stress

• May support improved fat metabolism

• May assist in maintenance of lean mass

• Can aid sleep quality because of improved GH pulse patterns

Mechanism of Action

CJC 1295 is a GHRH analogue which stimulates the pituitary gland to release growth hormone through the GHRH receptor pathway. Ipamorelin works through the ghrelin receptor pathway also known as the GHSR pathway which increases GH pulses without large changes in hunger signaling. When these two are used together they amplify natural GH rhythms from two separate receptor systems. This is why the combination is commonly studied for more consistent GH elevation rather than spike based activity.

Recommended Use

Researchers often prefer using a combined CJC and Ipamorelin formulation because it removes the need to mix two products separately. Research settings normally apply this product consistently for multiple weeks because GH signaling changes are cumulative. Better nutrition hydration and sleep patterns will enhance the visible impact of GH related improvements.

Safety and Side Effects

Possible side effects may include mild headache water retention tingling sensation or temporary fatigue particularly during early use. Because this is a peptide based GH signaling compound individuals with endocrine conditions must exercise caution. Avoid using during pregnancy or breastfeeding. Always store in a clean cool environment to maintain peptide stability.